MAMMAPRINT & BLUEPRINT®
Contact Breast Care Specialists of Carolina today to discuss your diagnosis and treatment options.
BREAST CANCER INDEX
Breast Cancer Index (BCI) is a test that provides information to help women diagnosed with early-stage, hormone receptor-positive (HR+) breast cancer, and their oncologists make personalized decisions about extending anti-estrogen (also called hormonal or endocrine) therapy beyond 5 years.
Breast Cancer Index is a test that looks at your initial tumor sample to provide two pieces of information:
Whether an additional 5 years of anti-estrogen therapy is likely to help reduce your risk of the cancer returning (recurrence) as metastatic disease.
Your individual risk of metastatic recurrence between 5 and 10 years after initial diagnosis, which is presented as a percentage risk [e.g., 3.2% or 7.5%].